T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$1.36B |
| 2 |
Philip Morris
PM
|
+$1.3B |
| 3 |
Amazon
AMZN
|
+$1.21B |
| 4 |
Stryker
SYK
|
+$1.12B |
| 5 |
AET
Aetna Inc
AET
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$1.46B |
| 2 |
Gilead Sciences
GILD
|
+$1.1B |
| 3 |
Walt Disney
DIS
|
+$866M |
| 4 |
Akamai
AKAM
|
+$703M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.69% |
| 2 | Consumer Discretionary | 15.01% |
| 3 | Financials | 13.64% |
| 4 | Technology | 12.55% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
MGE Energy Inc
MGEE
$3.06B
| $1.09M | ﹤0.01% |
20,860
+10
| +0% | +$492 |
|
|
MZTI
1677
The Marzetti Company
MZTI
$3.22B
| $1.08M | ﹤0.01% |
9,750
+1,200
| +14% | +$129K |
|
|
DHC
1678
Diversified Healthcare Trust
DHC
$2.03B
| $1.07M | ﹤0.01% |
59,802
+4,900
| +9% | +$76.5K |
|
1679
MDU Resources
MDU
$4.27B
| $1.07M | ﹤0.01% |
144,402
+13,484
| +10% | +$90.9K |
|
|
ENZY
1680
DELISTED
Enzymotec Ltd
ENZY
| $1.07M | ﹤0.01% |
304,445
| – | – |
|
|
DBD
1681
DELISTED
Diebold Nixdorf Incorporated
DBD
| $1.05M | ﹤0.01% |
36,360
+3,100
| +9% | +$81K |
|
|
PEI
1682
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $1.05M | ﹤0.01% |
3,204
+540
| +20% | +$161K |
|
|
BDN
1683
Brandywine Realty Trust
BDN
$542M
| $1.05M | ﹤0.01% |
74,733
+6,600
| +10% | +$84.5K |
|
|
LXK
1684
DELISTED
Lexmark Intl Inc
LXK
| $1.04M | ﹤0.01% |
31,127
+3,400
| +12% | +$100K |
|
1685
Credit Acceptance
CACC
$6.05B
| $1.04M | ﹤0.01% |
5,720
+2,800
| +96% | +$534K |
|
|
DEL
1686
DELISTED
Deltic Timber
DEL
| $1.04M | ﹤0.01% |
17,230
| – | – |
|
1687
CACI
CACI
$14.8B
| $1.03M | ﹤0.01% |
9,660
| – | – |
|
1688
Sarepta Therapeutics
SRPT
$1.95B
| $1.03M | ﹤0.01% |
52,768
+21,100
| +67% | +$369K |
|
|
RPAI
1689
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $1.03M | ﹤0.01% |
64,888
+4,000
| +7% | +$60.3K |
|
1690
Cinemark Holdings
CNK
$4.37B
| $1.03M | ﹤0.01% |
28,641
+2,607
| +10% | +$82.7K |
|
1691
Brookdale Senior Living
BKD
$3B
| $1.02M | ﹤0.01% |
64,560
+12,900
| +25% | +$197K |
|
1692
PBF Energy
PBF
$8.81B
| $1.02M | ﹤0.01% |
30,811
+5,016
| +19% | +$160K |
|
|
RPT
1693
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.02M | ﹤0.01% |
56,676
+15,273
| +37% | +$258K |
|
1694
Graham Holdings Company
GHC
$4.97B
| $1.02M | ﹤0.01% |
2,117
+360
| +20% | +$171K |
|
1695
Wendy's
WEN
$1.65B
| $1.01M | ﹤0.01% |
92,634
| – | – |
|
|
EFII
1696
DELISTED
Electronics for Imaging
EFII
| $1M | ﹤0.01% |
23,720
+4,300
| +22% | +$175K |
|
|
VMW
1697
DELISTED
VMware, Inc
VMW
| $1M | ﹤0.01% |
19,170
+1,304
| +7% | +$64.6K |
|
|
FMI
1698
DELISTED
Foundation Medicine, Inc.
FMI
| $999K | ﹤0.01% |
54,970
+60
| +0.1% | +$967 |
|
1699
Trustmark
TRMK
$2.8B
| $996K | ﹤0.01% |
43,229
+4,000
| +10% | +$88.1K |
|
1700
Advanced Micro Devices
AMD
$789B
| $991K | ﹤0.01% |
347,860
+105,696
| +44% | +$240K |
|
Similar funds
T. Rowe Price Associates's Q1 2016 Portfolio in Review
As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
- T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
- T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
- T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
- T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
- T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.
Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.